CXCR4 and breast carcinoma: The use of AMD3100 labeled with Gallium-68 in breast cancer-bearing mice demonstrated the potential of CXCR4 antagonists as imaging reagents on the one hand and reflects the significance of CXCR4 as a marker structure in cancer on the other hand [20].